格隆汇1月4日丨英派斯(002899.SZ)公布，公司收到海南江恒出具的《关于增持青岛英派斯健康科技股 份有限公司股份触及1%整数倍的告知函》，海南江恒于2025年12月29日至2025年12月31日期间通过集 中竞价的方式累计增持公司股份851,900股，占公司总股本的比例为0.58%，占剔除公司回购专用账户中 的股份数量后总股本的比例为0.58%，成交总金额为22,967,566元（不含交易费用等）。本次增持后， 海南江恒持有公司股份43,226,100股，占公司总股本的比例为29.25%，占剔除公司回购专用账户中的股 份数量后总股本的比例为29.50%，变动触及1%的整数倍。截至本公告日，海南江恒已累计增持 2,564,100股，占公司总股本的比例为1.73%，占剔除公司回购专用账户中的股份数量后总股本的比例为 1.75%，增持金额（不含交易费用）合计人民币66,712,307元。本次增持计划尚未实施完毕，海南江恒 将继续实施增持计划。 ...

Core Viewpoint - The company, Huida Technology (603160.SH), announced a share buyback plan by its controlling shareholder, actual controller, and some directors and senior management, reflecting their confidence in the company's long-term investment value and future development prospects [1] Group 1: Buyback Plan Details - The buyback plan is set to commence on April 9, 2025, and will last for 12 months, with a total planned investment amount ranging from RMB 40 million to RMB 60 million [1] - As of the announcement date, the buyback entities have already acquired a total of 391,400 shares, amounting to approximately RMB 27.401694 million [1] - The implementation of the buyback plan is still ongoing, and the entities will gradually proceed with the buyback based on market conditions during the implementation period [1]

Group 1 - The core point of the article is that Anner (002875.SZ) announced a shareholding increase by Jinxiangyuanduo No. 4 through centralized bidding, acquiring 2,123,500 shares, which represents 1.00% of the company's total share capital [1] - After this equity change, Jinxiangyuanduo No. 4 holds a total of 4,188,200 shares, accounting for 1.97% of the company's total share capital [1] - Together with Xinchuangyuan and its concerted action party Jinxiangyuanduo No. 4, they hold a total of 31,952,610 shares, which is 15.00% of the company's total share capital, reaching a multiple of 5% [1]

格隆汇12月29日丨 上美股份(02145.HK)公告，公司董事会获公司执行董事罗燕告知，罗燕于2025年12 月29日在公开市场以平均价每股约75.4608港元购入合共363,600股公司H股，总代价约为2744万港元。 紧随上述购买后，罗燕于合共2,867,200股股份中拥有权益，相当于本公告日期公司已发行股本总额 1.39%。于上述股份增持前，罗曾分别于2025年12月12日、16日、17日、18日及19日使用其个人资金购 入合共472,300股股份，总代价约为3890万港元。连同上述交易中购入的股份，截至本公告日期，其本 月总购股金额约为66.32百万港元，显示出其对公司未来发展的强大信心。 ...

Core Viewpoint - The controlling shareholder and chairman of Sente Group plans to increase his stake in the company to boost investor confidence and recognize the company's value [2][3]. Group 1: Shareholding Increase Plan - The chairman, Liu Aisen, intends to use personal or self-raised funds to purchase company shares [2]. - The planned investment amount is no less than RMB 100 million, with a maximum shareholding increase of 2% of the company's total equity within 12 months from the announcement date [2][3]. Group 2: Compliance and Regulations - The shareholding increase plan complies with relevant laws and regulations, including the Company Law and Securities Law, and will not trigger a mandatory takeover or change the company's control structure [4]. - The company will monitor the progress of the shareholding increase and fulfill its information disclosure obligations as per the Shanghai Stock Exchange regulations [5].

南财智讯12月24日电，江苏神通公告，信息披露义务人河北津西钢铁集团重工科技有限公司及其一致行 动人韩力、宁波聚源瑞利创业投资合伙企业（有限合伙）通过深圳证券交易所交易系统以集中竞价方式 增持公司股份。2025年12月11日至12月23日期间，津西重工增持507.55万股，占公司总股本的1.00%， 合计投资金额7627.64万元。本次权益变动后，津西重工及其一致行动人合计持有公司股份101,507,557 股，占总股本的20.00%。其中，津西重工持股912.90万股，占比1.80%；宁波聚源瑞利持股8267.86万 股，占比16.29%；韩力持股970.00万股，占比1.91%。本次变动股份中，除韩力部分股份为高管锁定 股、宁波聚源瑞利部分股份被质押外，其他股份无质押或冻结情形。信息披露义务人明确表示，非公司 第一大股东及实际控制人，本次变动未导致公司控制权变更。未来12个月内，不排除继续增持的可能， 拟增持金额不低于1亿元且不超过1.55亿元，资金来源为自有资金。 ...

格隆汇12月24日丨森特股份(603098.SH)公布，基于对公司未来发展的信心和对公司价值的认可，提振 投资者信心，切实维护投资者利益，公司控股股东、董事长兼总经理刘爱森先生拟以自有资金或自筹资 金增持公司股份。刘爱森先生计划自本公告披露日起12个月内通过上海证券交易所系统允许的方式增持 公司股份，计划增持金额不低于人民币1亿元，增持股份比例不超过公司总股本2%。 ...

Core Viewpoint - The company, Zhongyan Inner Mongolia Chemical Co., Ltd., has successfully completed its share repurchase plan, acquiring a total of 9,036,570 shares, which represents 0.616% of its total share capital, with a total expenditure of approximately 67.04 million yuan [4]. Group 1: Share Repurchase Approval and Plan - The company approved a share repurchase plan on December 5 and December 23, 2024, allowing for a repurchase of shares using self-owned and raised funds, with a budget between 50 million yuan and 100 million yuan [2]. - The repurchase price is capped at 12.60 yuan per share, with at least 50% of the funds allocated for maintaining company value and shareholder rights [2]. Group 2: Implementation of Share Repurchase - The first repurchase was executed on January 3, 2025, and the plan was completed by December 22, 2025, with shares repurchased at a maximum price of 7.98 yuan and a minimum price of 6.71 yuan, averaging 7.42 yuan per share [4]. - The execution of the repurchase plan adhered strictly to legal regulations, and there were no discrepancies between the actual execution and the disclosed plan [4]. Group 3: Shareholder Transactions - The company's chairman, Zhou Jie, planned to increase his shareholding by investing between 150,000 yuan and 200,000 yuan starting from September 20, 2024, and successfully acquired 23,900 shares by January 7, 2025 [5][6]. - No other directors, senior management, or major shareholders engaged in buying or selling company shares during the repurchase announcement period [6]. Group 4: Share Changes - The company reported changes in shareholding, including the cancellation of 5,390,824 restricted shares and the listing of 4,612,662 restricted shares during 2025 [6]. Group 5: Handling of Repurchased Shares - All repurchased shares will be stored in a dedicated account, with a maximum of 50% allocated for employee stock ownership plans or equity incentives, and the remaining for maintaining company value [7]. - If the repurchased shares are not utilized within 36 months, they will be canceled according to relevant laws and regulations [7].

Summary of Key Points Core Viewpoint - On December 23, several A-share listed companies disclosed their share buyback and reduction plans, indicating varying levels of confidence in their respective companies' future performance [1]. Group 1: Share Buybacks - Bowe Storage has completed a share buyback of 140 million yuan and plans to cancel the repurchased shares [2][3]. - BioShares intends to increase its stake in the company by 50 million to 100 million yuan [2][3]. - Huaxin Cement plans to buy back shares worth no less than 200 million yuan and no more than 400 million yuan [2][3]. - Weimais plans to repurchase shares for an amount between 50 million and 100 million yuan [2][3]. - Nova Star Cloud has secured financing support for a share buyback of up to 135 million yuan [2][3]. Group 2: Share Reductions - Hangyu Micro's shareholders Yan Jun and Wu Yuqi plan to reduce their stakes by no more than 1.66% and 0.36%, respectively [4]. - Yiwang Yichuang's shareholder Zhang Fan intends to reduce his stake by no more than 2.50% [4]. - Quan Feng Technology's fourth-largest shareholder, Hesheng Health, reduced its holdings by 31.89 million shares from December 19 to December 22 [4]. - Unisplendour's shareholder Chang'an Trust plans to reduce its stake by no more than 1% [4]. - Happy Home's shareholder has preliminarily set the transfer price at 19.43 yuan per share [4]. - Okoyi's shareholder Yuan Meihe plans to reduce his stake by no more than 1.89% [4].

格隆汇12月23日丨生物股份(600201.SH)公布，基于对公司未来持续稳定发展的信心和长期投资价值的 认可，增强投资者信心，生物控股计划自本公告披露之日起12个月内，通过上海证券交易所系统以集中 竞价方式增持公司股份，增持总金额不低于人民币5000万元，不超过人民币10000万元（以下简称"本次 增持计划"），本次增持计划不设置固定价格、价格区间，生物控股将基于对公司股票价值的合理判 断，并根据公司股票价格波动情况及资本市场整体趋势，择机实施本次增持计划。 ...